🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

European markets mostly down a day after ECB rate cut; Munich Re soars

Published 13/12/2024, 08:26
© Reuters.
UK100
-
FCHI
-
DE40
-
LCO
-
CL
-

Investing.com -- European markets slightly down on Friday as investors digested regional economic weakness in the wake of the European Central Bank’s latest interest rate cut.

At 11:40 ET (16:40 GMT), Germany’s DAX gained 0.01%, the UK’s FTSE 100 fell 0.15%, and France’s CAC gained 0.15%.

UK economy contracts again

The UK economy shrank by 0.1% in October, according to data released earlier Friday, marking its second consecutive monthly contraction, and cane as a surprise as a minor rebound from September's weakness had been expected. 

The contraction adds to concerns about the region’s economic outlook as businesses and households navigate persistent inflationary pressures and elevated borrowing costs.

At the same time, German exports fell by 2.8% in October, more than expected and an indication that the long-awaited recovery in external demand has been delayed.

Consumer prices in France were up 1.7% year-on-year in November, in line with its preliminary reading published late last month.

ECB and other central banks slash interest rates

Still, the European Central Bank has responded to this weakness, cutting interest rates on Thursday by 25 basis points, its fourth this year, and signaled the potential for more reductions in 2025. 

Elsewhere, the Swiss National Bank surprised markets with a larger-than-expected 50-basis-point cut, while Denmark’s central bank trimmed its rates by 25 basis points. 

Munich Re gains on strong guidance

In corporate news, Munich Re (ETR:MUVGn) stock rose over 5% after the reinsurer said it aims to achieve a net profit of €6 billion in 2025, citing strong operational performance across its business segments. 

Novo Nordisk (NYSE:NVO) stock fell about 3.9%, after Reuters reported that Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's (NYSE:LLY) Mounjaro over Novo Nordisk's Wegovy,

Oil prices higher amid supply concerns

Oil prices gained Friday as markets noted the potential of supply disruptions from tighter sanctions on Iran and Russia. 

At 11:40 ET Brent crude futures edged up 1.06% to $74.19 per barrel, while U.S. West Texas Intermediate crude rose 1.4% to $71 per barrel.

Sanctions targeting two of the world’s largest oil producers have raised concerns about potential supply constraints. 

However, the International Energy Agency (IEA) stated on Thursday that it expects the oil market to remain well-supplied through 2025, despite anticipating increased demand.

(Navamya Acharya contributed to this article.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.